Bausch Health Companies Inc.
NYSE:BHC · New York Stock Exchange
-$0.11 today
Vol 3.71M · Avg 1.70M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-21.80%
Period High
$8.34
Period Low
$4.76
Latest
$4.77
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.65B
Beam Therapeutics Inc.
NASDAQ:BEAM
$3.39B
Haemonetics Corporation
NYSE:HAE
$3.34B
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
$2.06B
ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
$1.79B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.79B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.69B
Perrigo Company plc
NYSE:PRGO
$1.37B
Alvotech
NASDAQ:ALVO
$1.22B
What is the latest BHC filing?
The latest filing shown is SD dated Jun 1, 2026.
How many recent filings does BHC have?
Intrinsic Alpha currently shows 20 recent filings for BHC.
Explore More
Continue the stock analysis
Jump to another research area for this company.